Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Construction and Validation of an Assessment Model of Pathological Complete Response After Neoadjuvant Treatment (NAT) on Breast Cancer Patients With Artificial Intelligence (AI) Technology

NCT05441098 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT05441098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05441098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Construction and Validation of an Assessment Model of Pathological Complete Response After Neoadjuvant Treatment (NAT) on Breast Cancer Patients With Artificial Intelligence (AI) Technology
Lead sponsor
Chinese Academy of Medical Sciences
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
December 31, 2022
Enrollment
1,821 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer